A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial
暂无分享,去创建一个
R. Gray | A. Goldstone | A. Burnett | K. Wheatley | R. Stevens | H. Walker | I. Hann | J. Rees | C. J. Harrison | C. Harrison